152 related articles for article (PubMed ID: 34674768)
1. Paradox of trimethylamine-N-oxide, the impact of malnutrition on microbiota-derived metabolites and septic patients.
Chou RH; Wu PS; Wang SC; Wu CH; Lu SF; Lien RY; Tsai YL; Lu YW; Kuo MR; Guo JY; Chou RY; Huang PH; Lin SJ
J Intensive Care; 2021 Oct; 9(1):65. PubMed ID: 34674768
[TBL] [Abstract][Full Text] [Related]
2. Circulating Trimethylamine N-Oxide Is Associated with Increased Risk of Cardiovascular Mortality in Type-2 Diabetes: Results from a Dutch Diabetes Cohort (ZODIAC-59).
Flores-Guerrero JL; van Dijk PR; Connelly MA; Garcia E; Bilo HJG; Navis G; Bakker SJL; Dullaart RPF
J Clin Med; 2021 May; 10(11):. PubMed ID: 34073908
[TBL] [Abstract][Full Text] [Related]
3. Increasing trimethylamine N-oxide levels as a predictor of early neurological deterioration in patients with acute ischemic stroke.
Hou L; Zhang Y; Zheng D; Shi H; Zou C; Zhang H; Lu Z; Du H
Neurol Res; 2020 Feb; 42(2):153-158. PubMed ID: 31928326
[No Abstract] [Full Text] [Related]
4. Plasma Trimethylamine-N-Oxide Is an Independent Predictor of Long-Term Cardiovascular Mortality in Patients Undergoing Percutaneous Coronary Intervention for Acute Coronary Syndrome.
Eyileten C; Jarosz-Popek J; Jakubik D; Gasecka A; Wolska M; Ufnal M; Postula M; Toma A; Lang IM; Siller-Matula JM
Front Cardiovasc Med; 2021; 8():728724. PubMed ID: 34778397
[TBL] [Abstract][Full Text] [Related]
5. Microbiota-dependent metabolite trimethylamine-N-oxide is associated with disease severity and survival of patients with chronic heart failure.
Trøseid M; Ueland T; Hov JR; Svardal A; Gregersen I; Dahl CP; Aakhus S; Gude E; Bjørndal B; Halvorsen B; Karlsen TH; Aukrust P; Gullestad L; Berge RK; Yndestad A
J Intern Med; 2015 Jun; 277(6):717-26. PubMed ID: 25382824
[TBL] [Abstract][Full Text] [Related]
6. Gut, microbiota-dependent trimethylamine-N-oxide is associated with long-term all-cause mortality in patients with exacerbated chronic obstructive pulmonary disease.
Ottiger M; Nickler M; Steuer C; Bernasconi L; Huber A; Christ-Crain M; Henzen C; Hoess C; Thomann R; Zimmerli W; Mueller B; Schuetz P
Nutrition; 2018 Jan; 45():135-141.e1. PubMed ID: 28870405
[TBL] [Abstract][Full Text] [Related]
7. Gut microbiota-derived metabolite trimethylamine N-oxide as a biomarker in early Parkinson's disease.
Chung SJ; Rim JH; Ji D; Lee S; Yoo HS; Jung JH; Baik K; Choi Y; Ye BS; Sohn YH; Yun M; Lee SG; Lee PH
Nutrition; 2021 Mar; 83():111090. PubMed ID: 33418492
[TBL] [Abstract][Full Text] [Related]
8. Gut Microbiota-Dependent Trimethylamine N-Oxide Associates With Inflammation in Common Variable Immunodeficiency.
Macpherson ME; Hov JR; Ueland T; Dahl TB; Kummen M; Otterdal K; Holm K; Berge RK; Mollnes TE; Trøseid M; Halvorsen B; Aukrust P; Fevang B; Jørgensen SF
Front Immunol; 2020; 11():574500. PubMed ID: 33042155
[TBL] [Abstract][Full Text] [Related]
9. Gut microbiota-dependent trimethylamine N-oxide (TMAO) pathway contributes to both development of renal insufficiency and mortality risk in chronic kidney disease.
Tang WH; Wang Z; Kennedy DJ; Wu Y; Buffa JA; Agatisa-Boyle B; Li XS; Levison BS; Hazen SL
Circ Res; 2015 Jan; 116(3):448-55. PubMed ID: 25599331
[TBL] [Abstract][Full Text] [Related]
10. Intestinal microbiota-dependent phosphatidylcholine metabolites, diastolic dysfunction, and adverse clinical outcomes in chronic systolic heart failure.
Tang WH; Wang Z; Shrestha K; Borowski AG; Wu Y; Troughton RW; Klein AL; Hazen SL
J Card Fail; 2015 Feb; 21(2):91-6. PubMed ID: 25459686
[TBL] [Abstract][Full Text] [Related]
11. Trimethylamine N-oxide and outcomes in patients hospitalized with acute heart failure and preserved ejection fraction.
Kinugasa Y; Nakamura K; Kamitani H; Hirai M; Yanagihara K; Kato M; Yamamoto K
ESC Heart Fail; 2021 Jun; 8(3):2103-2110. PubMed ID: 33734604
[TBL] [Abstract][Full Text] [Related]
12. Association between trimethylamine N-oxide and prognosis of patients with acute myocardial infarction and heart failure.
Li N; Zhou J; Wang Y; Chen R; Li J; Zhao X; Zhou P; Liu C; Song L; Liao Z; Wang X; Yan S; Zhao H; Yan H
ESC Heart Fail; 2022 Dec; 9(6):3846-3857. PubMed ID: 35686339
[TBL] [Abstract][Full Text] [Related]
13. Advanced chronic kidney disease populations have elevated trimethylamine N-oxide levels associated with increased cardiovascular events.
Kim RB; Morse BL; Djurdjev O; Tang M; Muirhead N; Barrett B; Holmes DT; Madore F; Clase CM; Rigatto C; Levin A;
Kidney Int; 2016 May; 89(5):1144-1152. PubMed ID: 27083288
[TBL] [Abstract][Full Text] [Related]
14. Plasma trimethylamine N-oxide, a gut microbe-generated phosphatidylcholine metabolite, is associated with autism spectrum disorders.
Quan L; Yi J; Zhao Y; Zhang F; Shi XT; Feng Z; Miller HL
Neurotoxicology; 2020 Jan; 76():93-98. PubMed ID: 31704102
[TBL] [Abstract][Full Text] [Related]
15. A Multi-omic Association Study of Trimethylamine N-Oxide.
Manor O; Zubair N; Conomos MP; Xu X; Rohwer JE; Krafft CE; Lovejoy JC; Magis AT
Cell Rep; 2018 Jul; 24(4):935-946. PubMed ID: 30044989
[TBL] [Abstract][Full Text] [Related]
16. Circulating trimethylamine N-oxide levels do not predict 10-year survival in patients with or without coronary heart disease.
Bjørnestad EØ; Dhar I; Svingen GFT; Pedersen ER; Ørn S; Svenningsson MM; Tell GS; Ueland PM; Sulo G; Laaksonen R; Nygård O
J Intern Med; 2022 Dec; 292(6):915-924. PubMed ID: 35916742
[TBL] [Abstract][Full Text] [Related]
17. Association of Circulating Trimethylamine-N Oxide With Malnutrition and the Risk of Coronary Artery Disease in Patients With Maintenance Hemodialysis.
Yuan X; Wei X; Liu J; Tang C; Peng L; Wang H; Huang Y
J Ren Nutr; 2023 May; 33(3):465-471. PubMed ID: 36549408
[TBL] [Abstract][Full Text] [Related]
18. Associations of Trimethylamine N-Oxide With Nutritional and Inflammatory Biomarkers and Cardiovascular Outcomes in Patients New to Dialysis.
Kaysen GA; Johansen KL; Chertow GM; Dalrymple LS; Kornak J; Grimes B; Dwyer T; Chassy AW; Fiehn O
J Ren Nutr; 2015 Jul; 25(4):351-6. PubMed ID: 25802017
[TBL] [Abstract][Full Text] [Related]
19. Prognostic value of choline and betaine depends on intestinal microbiota-generated metabolite trimethylamine-N-oxide.
Wang Z; Tang WH; Buffa JA; Fu X; Britt EB; Koeth RA; Levison BS; Fan Y; Wu Y; Hazen SL
Eur Heart J; 2014 Apr; 35(14):904-10. PubMed ID: 24497336
[TBL] [Abstract][Full Text] [Related]
20. Gut microbiota-derived trimethylamine N-oxide is associated with poor prognosis in patients with heart failure.
Li W; Huang A; Zhu H; Liu X; Huang X; Huang Y; Cai X; Lu J; Huang Y
Med J Aust; 2020 Oct; 213(8):374-379. PubMed ID: 32959366
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
